About Neomi Pharmaceuticals
Neomi Pharmaceuticals is a company based in India. Neomi Pharmaceuticals offers products and services including Pharmaceutical Formulations and Nutraceutical Formulations.
- Headquarter India
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Social LinkedIn
- Legal Name Neomi Pharmaceuticals Pvt. Ltd
- Date of Incorporation 06 Feb, 2016
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹27.11 Cr
FY 2025 · -12% YoY
- Net Profit₹44.7 Lakh
FY 2025 · 2% margin
- EBITDA₹72.7 Lakh
FY 2025 · 3% margin
Associated legal entities of Neomi Pharmaceuticals
Neomi Pharmaceuticals operates through Neomi Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Neomi Pharmaceuticals Private Limited CIN U46497MH2016PTC272811 | Active | 06 Feb 2016 | Mumbai, Maharashtra | ₹27.1 Cr | – | 2 | View details |
Products & Services of Neomi Pharmaceuticals
Neomi Pharmaceuticals offers a comprehensive portfolio of products and services, including Pharmaceutical Formulations and Nutraceutical Formulations.
High-quality pharmaceutical formulations are manufactured and exported in various dosage forms to support health needs.
Nutraceutical formulations are produced and supplied for wellness purposes, focusing on safety and efficacy.
Board of directors of Neomi Pharmaceuticals Private Limited (Neomi Pharmaceuticals)
Neomi Pharmaceuticals Private Limited is the primary company behind Neomi Pharmaceuticals. The board of Neomi Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Jetal Amit Sota, appointed in 2016.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Jetal Amit Sota DIN 07391083 | Director | 06 Feb 2016 | 10 yrs 8 mo | Neomi Pharmaceuticals Private Limited |
| Amit Rajnikant Sota DIN 07391082 | Director | 06 Feb 2016 | 10 yrs 8 mo | Neomi Pharmaceuticals Private Limited |
Financials of Neomi Pharmaceuticals
Figures of Neomi Pharmaceuticals Private Limited, the primary company behind Neomi Pharmaceuticals, for FY 2025. Revenue was ₹27.11 Cr (-12% year on year). Net profit was ₹44.7 Lakh (2% margin). EBITDA was ₹72.7 Lakh (3% margin). Revenue has grown at a compounded annual rate of +38% over three years and +60% over five years.
- ₹27.11 CrRevenue · FY 2025 · -12% YoY
- ₹44.7 LakhNet profit · 2% margin
- ₹72.7 LakhEBITDA · 3% margin
- ₹4 LakhPaid-up capital
- +38%Revenue CAGR, 3 years
- +60%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Neomi Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Neomi Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Neomi Pharmaceuticals
10 companies that operate in the same segment as Neomi Pharmaceuticals (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Neomi Pharmaceuticals
Neomi Pharmaceuticals is headquartered in India.
The primary company behind Neomi Pharmaceuticals, Neomi Pharmaceuticals Private Limited, reported revenue of ₹27.11 Cr for FY 2025, down 12% year on year.
Neomi Pharmaceuticals Pvt. Ltd. was established in February 2016 and is regarded as a key player in the healthcare sector. It is known for producing and exporting a variety of pharmaceutical, herbal, and nutraceutical formulations across continents, with an emphasis on innovation, quality assurance, and ethical practices. Regulatory approvals from entities like WHO GMP and EU GMP are maintained to ensure product safety and efficacy. The companys commitment to integrity and responsible business practices is evident in its global operations and supply chain management, fostering trust among stakeholders.
Neomi Pharmaceuticals offers Pharmaceutical Formulations and Nutraceutical Formulations.
Neomi Pharmaceuticals operates through Neomi Pharmaceuticals Private Limited.
The legal entities of Neomi Pharmaceuticals currently have 2 directors, including Jetal Amit Sota, Amit Rajnikant Sota.